Younger Age Is Associated With Favorable Outcomes in Adult Dogs With Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results From the PRO-DOX Study

Version
Younger Age Is Associated With Favorable Outcomes in Adult Dogs With Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results From the PRO-DOX Study

Younger Age Is Associated With Favorable Outcomes in Adult Dogs With Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results From the PRO-DOX Study